Telehealth Depression Prescribing: What PMHNPs Can Do in California

If you’re a psychiatrist or PMHNP considering telepsychiatry — or already practicing remotely — you’ve probably asked: Can I legally prescribe antidepressants and other depression medications through telehealth? The short answer: yes, absolutely. But the longer answer depends on your provider type, which state your patient is in, and whether you’re treating with controlled versus non-controlled medications.

Here’s the reality: depression treatment via telehealth is one of the most straightforward areas of telepsychiatry from a regulatory standpoint. First-line antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, etc.) are non-controlled substances, which means you don’t face the federal prescribing barriers that apply to stimulants or opioids. No in-person exam required under the Ryan Haight Act. No DEA special waiver needed. You can conduct a video evaluation, diagnose major depressive disorder, and e-prescribe sertraline or escitalopram to your patient’s local pharmacy — all perfectly legal under current telehealth rules.

That said, the details matter. Your scope of practice varies significantly by state if you’re a PMHNP. Your reimbursement depends on payer mix and telehealth parity laws. And if you’re treating complex depression cases that require adjunctive controlled substances (benzodiazepines for anxiety, stimulants for treatment-resistant depression), federal flexibilities apply through at least the end of 2025 — but permanent rules are still being finalized.

Let’s break down what psychiatrists and PMHNPs can actually do in telehealth depression care, state by state, and what it means for your practice economics.

What Psychiatrists Can Do: Full Authority, No Strings Attached

If you’re a psychiatrist (MD or DO), your prescriptive authority for depression is unlimited across all states. You can evaluate, diagnose, and prescribe any medication indicated for major depressive disorder — whether via video visit or in your office. This includes:

• SSRIs/SNRIs (sertraline, escitalopram, venlafaxine, duloxetine)
• Atypical antidepressants (bupropion, mirtazapine, trazodone)
• Tricyclics (nortriptyline, amitriptyline for treatment-resistant cases)
• MAOIs (phenelzine, tranylcypromine when appropriate)
• Augmentation agents (aripiprazole, quetiapine, lithium)
• Controlled substances when clinically indicated (benzodiazepines for comorbid anxiety, stimulants for augmentation)

There’s no physician supervision requirement — you answer only to your medical license, DEA registration, and standard of care. The telehealth modality doesn’t limit your prescribing power at all.

The Telehealth Workflow for Psychiatrists

A typical depression management workflow via telehealth looks like this:

1. Initial evaluation (60 minutes): Video assessment, mental status exam, suicide risk screening, diagnostic clarification. Bill CPT 90792 or extended E/M code (often reimbursed $200+ from commercial insurance).

2. Medication initiation: E-prescribe an SSRI or other first-line agent. Many platforms integrate with Surescripts for direct pharmacy transmission.

3. Follow-up at 2-4 weeks: Brief video check (15-30 minutes) to assess response, side effects, adherence. Bill CPT 99213 or 99214 (typically $80-$130 reimbursement depending on complexity and payer).

4. Titration and monitoring: Adjust dose, add augmentation if needed, coordinate with therapy. Frequent touch points early improve outcomes and reduce no-shows.

5. Maintenance: Once stable, schedule every 4-8 weeks for medication management. Track symptoms with PHQ-9 scores electronically.

You can do all of this remotely, and insurance pays at the same rate as in-person visits in most states thanks to telehealth parity laws (44 states + DC mandate coverage; 23 states mandate equal payment). Medicare also reimburses telehealth mental health visits at full rates through at least 2025, with ongoing extensions likely given bipartisan support.

State Licensing: The Main Barrier to Expansion

The catch? You must be licensed in the state where the patient is physically located during the telehealth session. If you’re licensed only in California but want to see a patient in Texas, you need a Texas medical license.

The good news: 37 states participate in the Interstate Medical Licensure Compact (IMLC), which streamlines multi-state licensing for physicians. Apply once, expedite licenses in multiple compact states, expand your telehealth reach. This is especially valuable in high-demand states like Texas (1 psychiatrist per 9,000 residents) and Florida (1 per 8,500), where you can fill critical gaps.

Controlled Substance Prescribing via Telehealth

Depression pharmacotherapy usually doesn’t involve DEA Schedule II medications — but sometimes it does (treatment-resistant depression augmented with amphetamine, severe anxiety with short-term clonazepam, etc.).

Federal COVID-era flexibilities remain extended through December 31, 2025: you can prescribe controlled substances via telehealth without an initial in-person exam, as long as you conduct a legitimate audio-video evaluation. The DEA has postponed finalizing permanent telemedicine prescribing rules multiple times, so current temporary rules continue.

For psychiatrists, this means you can legally manage comorbid anxiety with benzodiazepines or prescribe stimulant augmentation for depression via telehealth nationwide — at least through 2025. Most expect permanent rules will allow some form of tele-prescribing for mental health given the demonstrated safety record during the pandemic, but stay alert for DEA rulemaking updates.

Bottom line for psychiatrists: Telepsychiatry for depression is wide open. You have full prescriptive authority, equal reimbursement, and regulatory support for remote care. The only hurdle is getting licensed in the states where you want to practice.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNPs: It Depends Which State You’re In

If you’re a Psychiatric Mental Health Nurse Practitioner (PMHNP), your prescribing authority for depression varies dramatically by state. Unlike psychiatrists, who practice under a universal medical license framework, NPs practice under nursing licenses with state-specific scope of practice rules.

As of 2026, states fall into three categories:

• Full Practice Authority: NPs can evaluate, diagnose, and prescribe independently — no physician oversight required.
• Reduced Practice: NPs can prescribe but need a collaborative agreement or some physician involvement.
• Restricted Practice: NPs require continuous physician supervision or delegation for prescribing.

Let’s look at how this plays out in the priority states where Klarity operates:

New York: Full Practice, Nearly Equal to MDs

New York became a full practice state in 2022 when the Nurse Practitioner Modernization Act was made permanent. If you’re a PMHNP with 3,600+ hours of practice experience, you no longer need a collaborative agreement with a physician to prescribe.

In practical terms: You can independently manage depression patients via telehealth in New York. Initial eval, prescribe Zoloft, follow-up visits, adjust dosing, add Wellbutrin — all without physician sign-off. You have your own DEA registration for controlled substances. For prescribing authority, you’re essentially on par with an MD.

The main difference? Medicare reimburses NPs at 85% of the physician fee schedule when you bill under your own NPI (so that $120 med check a psychiatrist gets paid might be $102 for an NP). But from a scope standpoint, New York PMHNPs have full autonomy.

California: Transitioning to Full Practice by 2026

California historically had some of the most restrictive NP rules — you needed ‘standardized procedures’ developed with a supervising physician just to prescribe. AB 890 changed everything.

As of 2023, experienced NPs who meet criteria can practice without physician supervision in certain healthcare settings (hospitals, clinics, group practices). By January 1, 2026, qualified NPs can obtain a special Board certification allowing independent practice in any setting — including telehealth platforms and private practice.

If you’re a California PMHNP who’s already met the requirements (typically master’s degree, national certification, ~3 years supervised practice), you can prescribe depression medications autonomously in 2026. You can evaluate patients, prescribe SSRIs, manage medication adjustments, order labs — no MD involvement needed.

Until you obtain that certification, though, California still requires physician collaboration via standardized procedures. So there’s a transitional period where some PMHNPs are practicing independently and others aren’t, depending on experience level and certification status.

For a telehealth platform: California is moving toward PMHNP-MD parity, but you still need to track which NPs have independent authority versus which need collaborative oversight.

Pennsylvania: Reduced Practice — Collaborative Agreements Required

Pennsylvania is a reduced practice state. PMHNPs must have a collaborative agreement with a physician to prescribe medications.

The physician doesn’t need to co-sign every prescription, but the agreement must outline your scope of practice, medication categories, and physician availability for consultation. The agreement must be filed with the state Board of Nursing.

In practice: You can manage depression patients via telehealth in Pennsylvania, prescribe antidepressants, do med checks — but you can’t operate in a vacuum. Your collaborating physician (often a psychiatrist or family doctor) needs to be available for consult and might review a percentage of your charts periodically.

For solo practitioners, this means finding a willing collaborating physician (who may charge a fee for oversight). For a platform like Klarity, this means ensuring PMHNP providers in PA have a collaborative agreement in place, either with an MD on the platform or with their own established relationship.

Psychiatrists in Pennsylvania have no such requirement — they prescribe independently. So if you’re an MD, you have more operational flexibility in PA than a PMHNP does.

Illinois: Reduced Practice, But Full Authority Available for Experienced NPs

Illinois is technically a reduced practice state, but offers a pathway for experienced PMHNPs to achieve Full Practice Authority (FPA).

If you complete 4,000 hours of practice under a collaborative agreement plus additional training, you can apply for an Illinois FPA license. Once granted, you can practice without a written collaborative agreement in your specialty area.

However, even FPA NPs in Illinois face one restriction: to prescribe certain controlled substances (like benzodiazepines or Schedule II narcotics), you need a consultation relationship with a physician. This doesn’t mean the physician supervises you — just that you have someone available to consult on complex cases.

For depression treatment: If you have Illinois FPA status, you can independently prescribe SSRIs, SNRIs, bupropion, mirtazapine, and most antidepressants. If a patient needs a benzodiazepine for severe anxiety or a stimulant for augmentation, you’d consult with an MD (often just a phone call or documented discussion), but you’re still the prescriber of record.

If you don’t have FPA status yet, you need a formal collaborative agreement like Pennsylvania.

For platforms: Illinois offers experienced PMHNPs near-parity with psychiatrists, but newer NPs still operate under collaborative agreements.

Texas: Restricted Practice — Heavy Physician Oversight

Texas has one of the most restrictive NP practice environments in the country. PMHNPs cannot prescribe any medication — including non-controlled antidepressants — without a formal Prescriptive Authority Agreement with a physician.

The supervising physician must:

• Sign a written delegation agreement outlining your prescriptive scope
• Review a percentage of your charts regularly
• Be available for consultation
• Meet with you periodically (in-person or virtually)

Additionally, Texas prohibits NPs from prescribing Schedule II controlled substances in most outpatient settings (hospital and hospice exceptions exist). So if you’re treating treatment-resistant depression with stimulant augmentation, you’d need the collaborating physician to prescribe that medication.

For depression care specifically: A PMHNP in Texas can evaluate patients via telehealth and prescribe SSRIs, SNRIs, trazodone, etc. — but only under an MD’s delegation. The telehealth modality doesn’t change the supervision requirement; Texas law applies whether you’re seeing patients in-person or remotely.

Psychiatrists in Texas face no such limitations — they prescribe independently. Given Texas’s severe psychiatrist shortage (1 per 9,000 residents), there’s enormous demand for psychiatric services, but PMHNPs operate at a distinct disadvantage without physician collaboration.

A 2023 bill (SB 1700) attempted to grant Texas NPs full practice authority, but it failed. As of 2026, nothing has changed.

For telehealth platforms operating in Texas: You either need to recruit psychiatrists (who can work independently) or arrange physician oversight for PMHNPs (adding operational complexity).

Florida: Restricted Practice — Psych NPs Excluded from Autonomous Category

Florida created a category of ‘Autonomous Practice’ for advanced practice registered nurses (APRNs) in 2020 — but only for primary care specialties (family medicine, pediatrics, internal medicine) and midwifery.

Psychiatric NPs were explicitly excluded.

This means PMHNPs in Florida must practice under a written protocol with a supervising physician, regardless of experience level. The protocol outlines your scope, prescriptive authority, and physician oversight requirements.

Florida does allow NPs to prescribe controlled substances under supervision, with some restrictions:

• Schedule II prescriptions for acute pain limited to 7-day supply
• NPs (except psych specialists) cannot prescribe stimulants to minors
• PMHNPs can prescribe stimulants and benzodiazepines to adults if the supervising physician delegates that authority

For depression treatment: A Florida PMHNP can prescribe antidepressants via telehealth, but only under a physician protocol. If treating comorbid anxiety with a benzodiazepine or using stimulant augmentation, the protocol must specifically authorize those medications.

Florida also has strict e-prescribing requirements and mandatory PDMP (prescription drug monitoring program) checks before prescribing controlled substances.

Psychiatrists in Florida prescribe independently with no supervision. Given Florida’s high demand (1 psychiatrist per 8,500 residents), collaborating with PMHNPs under proper oversight can expand capacity — but it requires physician infrastructure that MDs alone don’t need.

The Economics of Telehealth Depression Treatment: Why Reimbursement Matters

Let’s talk money. You’re not joining a telehealth platform out of altruism — you want to see more patients, reduce administrative burden, and maintain (or grow) your income. Understanding how medication management gets reimbursed via telehealth is critical.

Standard Reimbursement: E/M Codes

Most psychiatrists billing insurance for medication management use evaluation and management (E/M) codes:

• 99213 (15-minute established patient visit, low complexity): ~$80-$100 average reimbursement
• 99214 (30-minute established patient visit, moderate complexity): ~$120-$130 average reimbursement
• 99215 (45-minute established patient visit, high complexity): ~$150-$180

Initial psychiatric evaluations use 90792 (psychiatric diagnostic evaluation) or extended E/M codes and typically reimburse $200+.

When delivered via telehealth, these codes are billed with a telehealth modifier (95 or GT) or telehealth place-of-service code (02). Thanks to telehealth parity laws, commercial insurers reimburse these visits at the same rate as in-person in most states.

As of 2025, 44 states + DC mandate telehealth coverage, and 23 states explicitly require equal payment for virtual visits. Among priority states:

• New York: Strong parity law — telehealth visits reimbursed ‘on the same basis and at the same rate’ as in-person
• Illinois: Permanent payment parity enacted 2021
• California and Pennsylvania: Telehealth coverage laws in place; most insurers pay parity for mental health services
• Texas: Telehealth Medicaid pays at parity; private insurers often follow suit
• Florida: Coverage parity but not mandated equal rates; in practice, most major insurers pay the same

Medicare has extended tele-mental health flexibilities through at least the end of 2025 (with ongoing congressional extensions likely). Medicare pays E/M codes for telehealth visits at the same rates as office visits — so a 99214 might reimburse ~$115 from Medicare regardless of modality.

The Medicare catch for NPs: Medicare reimburses nurse practitioners at 85% of the physician fee schedule when billing under the NP’s own NPI. So that $120 visit a psychiatrist gets paid becomes ~$102 for an NP. (Exception: if the NP bills ‘incident-to’ a physician, Medicare pays 100% — but incident-to billing is difficult in telehealth since the physician usually isn’t present.)

For platforms like Klarity, this means psychiatrists generate slightly higher per-visit revenue from Medicare patients than PMHNPs do. But for commercial insurance (which makes up most telepsychiatry volume), PMHNPs and MDs are reimbursed equally.

Why Telehealth Economics Favor Medication Management

Psychiatrists providing medication management (vs. therapy) can see more patients per day with shorter appointment slots (15-30 minutes vs. 45-60 minutes for therapy). If you’re doing 20-minute med checks at $100-120 each, you can realistically see 12-16 patients in an 8-hour day, generating $1,400-2,000 in collections.

Telehealth removes geographic friction: no commute for patients, no office overhead for you (if you’re working independently or with a platform). Patients are more likely to keep appointments when they can log in from home. No-show rates for tele-mental health visits are typically lower than in-person.

Platforms like Klarity handle:

• Patient acquisition and marketing (no $3,000-5,000/month ad spend on your end)
• Scheduling and EHR infrastructure
• Insurance credentialing and billing (or cash-pay collection)
• Telehealth technology (HIPAA-compliant video, e-prescribing integration)

You pay a per-appointment fee (similar to Zocdoc’s model) rather than upfront marketing costs or monthly platform subscriptions. That means guaranteed ROI: you only pay when you actually see a patient. Compare that to DIY marketing where you might spend $200-500+ acquiring a single qualified psychiatric patient (when you factor in SEO agencies, Google Ads cost-per-click at $15-40 for mental health keywords, directory listing fees, staff time qualifying leads, and no-show rates).

For a psychiatrist or PMHNP starting out or scaling up, this model eliminates financial risk. You’re not gambling $5,000/month on marketing channels with uncertain results — you’re paying a known cost per patient and building a practice with predictable economics.

Controlled Substance Prescribing: The Fine Print

Most depression treatment involves non-controlled medications (SSRIs, SNRIs, mirtazapine, bupropion, tricyclics). These can be prescribed via telehealth with no extra federal restrictions — just follow standard of care and state licensing requirements.

But what about adjunctive controlled substances? Benzodiazepines for severe anxiety, stimulants for treatment-resistant depression augmentation, sleep aids like zolpidem?

Under normal DEA rules (Ryan Haight Act), prescribing controlled substances via telemedicine requires an initial in-person medical evaluation. But during COVID-19, the DEA waived this requirement for mental health treatment, allowing providers to prescribe controlled substances after a legitimate audio-video telemedicine evaluation.

This waiver has been extended multiple times. As of late 2024, the DEA announced the flexibilities will remain in place through December 31, 2025. The DEA and HHS are working on permanent telemedicine prescribing regulations, but they’ve been delayed repeatedly.

What this means for depression providers in 2026:

• You can prescribe benzodiazepines (clonazepam, lorazepam) for comorbid anxiety via telehealth, as long as you conduct a proper evaluation and document clinical rationale.
• You can prescribe stimulants (Adderall, Vyvanse) for depression augmentation via telehealth under current temporary rules.
• You can prescribe sleep aids (zolpidem, eszopiclone) for insomnia comorbid with depression.

However, be mindful:

• Some states have additional restrictions on controlled substance tele-prescribing (though most aligned with federal flexibilities during COVID).
• Florida, for example, prohibits telemedicine prescribing of controlled substances for chronic non-cancer pain (but mental health treatment is exempt).
• Best practice: Document thorough evaluations, use state PDMPs (prescription drug monitoring programs) to check for controlled substance history, and only prescribe controlled substances when clinically indicated.

After 2025: Expect permanent DEA rules to allow some form of tele-prescribing for mental health controlled substances, given the demonstrated safety and necessity during the pandemic. But until final rules are published, plan for potential changes and stay alert to DEA announcements.

FAQs: Depression Prescribing via Telehealth

Can a PMHNP prescribe antidepressants via telehealth?

Yes, in all states — but scope varies. In full practice states (New York, soon California), PMHNPs can prescribe independently. In reduced/restricted practice states (Pennsylvania, Illinois, Texas, Florida), PMHNPs need a collaborative agreement or physician supervision. The telehealth modality doesn’t add extra barriers; state scope-of-practice laws apply whether you’re seeing patients virtually or in-person.

Do I need an in-person visit before prescribing depression medications via telehealth?

No. Depression medications (SSRIs, SNRIs, etc.) are non-controlled substances, so the Ryan Haight Act’s in-person exam requirement doesn’t apply. You can conduct an initial evaluation via audio-video telehealth and prescribe antidepressants the same day. For controlled substances (benzodiazepines, stimulants), temporary federal waivers allow tele-prescribing without an in-person exam through at least the end of 2025.

Does insurance reimburse telehealth medication management the same as in-person visits?

Yes, in most cases. 44 states + DC mandate telehealth coverage, and 23 states require payment parity. Medicare reimburses tele-mental health visits at the same rate as office visits through at least 2025. Average reimbursement for a 30-minute med check (CPT 99214) is ~$120-$130 from commercial insurance, whether delivered via video or in-office.

Can psychiatrists prescribe controlled substances via telehealth for depression?

Yes, under current temporary DEA flexibilities (extended through December 31, 2025). You can prescribe benzodiazepines for comorbid anxiety, stimulants for treatment-resistant depression augmentation, or sleep aids via telehealth after conducting a legitimate audio-video evaluation. Permanent rules are pending, but mental health tele-prescribing is expected to remain viable given the demonstrated safety record during COVID.

What’s the difference between MD and PMHNP prescribing authority for depression?

Psychiatrists (MD/DO) have full independent prescribing authority in all states — no supervision or collaborative agreements required. PMHNPs have authority that varies by state: full independence in states like New York and (soon) California, but physician collaboration required in states like Pennsylvania, Texas, and Florida. For depression treatment specifically, both can prescribe first-line antidepressants, but MDs have more autonomy and fewer administrative hurdles in restricted-practice states.

Do I need separate licenses to practice telepsychiatry in multiple states?

Yes. You must be licensed in the state where the patient is physically located during the telehealth session. Psychiatrists can use the Interstate Medical Licensure Compact (IMLC) to expedite multi-state licensing across 37 participating states. PMHNPs also need licenses in each state where they practice, and scope-of-practice rules apply per state (so an NP with full practice authority in New York would still need a collaborative agreement if seeing patients in Texas).

Can PMHNPs prescribe benzodiazepines or stimulants for depression via telehealth?

It depends on the state. In full practice states (New York, soon California), PMHNPs can prescribe controlled substances independently (with their own DEA registration). In reduced/restricted states, it depends on the collaborative agreement or state-specific limits. For example:

• Illinois: FPA-status NPs can prescribe but must consult a physician for benzodiazepines or Schedule II drugs.
• Texas: NPs generally cannot prescribe Schedule II outpatient; benzodiazepines allowed under physician delegation.
• Florida: NPs can prescribe controlled substances under physician protocol, with some restrictions (e.g., Schedule II for acute pain limited to 7 days).

Always verify your state’s specific rules for controlled substance prescribing by NPs.

How much does a psychiatrist typically earn per telehealth depression visit?

Average reimbursement for a 30-minute medication management visit (CPT 99214) is $120-$130 from commercial insurance. A 15-minute visit (99213) typically reimburses $80-$100. Medicare pays ~$115 for 99214. Initial evaluations (90792 or extended E/M codes) often reimburse $200+. With telehealth efficiency (no commute, back-to-back scheduling), psychiatrists can realistically see 12-16 patients per day, generating $1,400-2,000 in daily collections.

Why Join a Platform Like Klarity for Depression Prescribing?

If you’re a psychiatrist or PMHNP reading this, you’re probably wondering: Should I build my own telehealth practice or join a platform?

Here’s the honest math:

DIY telehealth practice costs:

• SEO agency or consultant: $1,500-3,000/month (6-12 months before meaningful results)
• Google Ads for ‘psychiatrist near me’ or ‘online depression treatment’: $15-40 per click, $200-500+ cost per booked patient after factoring in conversion rates and no-shows
• Directory listings (Psychology Today, Zocdoc): $50-200/month subscription + per-booking fees ($35-100 per patient on Zocdoc)
• Telehealth platform subscription: $50-200/month (Doxy.me, SimplePractice)
• EHR with e-prescribing: $100-300/month
• Credentialing with insurance networks: $2,000-5,000 upfront + 90-180 day wait for approval
• Staff time to answer calls, qualify leads, schedule appointments
• Total upfront investment before seeing your first patient: $5,000-10,000+ and 3-6 months of lead time

Klarity model:

• Zero upfront marketing spend — Klarity handles patient acquisition
• Pay per appointment — standard listing fee per new patient lead (similar to Zocdoc’s model)
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure — no separate platform costs
• Insurance credentialing handled — both insurance and cash-pay patient flow
• You control your schedule — only see patients when you want, only pay when you do

The value proposition: instead of gambling $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. the lottery of DIY patient acquisition.

For psychiatrists and PMHNPs treating depression, this removes the biggest barrier to scaling: finding patients who actually need your services. Klarity’s patient matching means you’re not wasting time on no-shows or unqualified leads — you’re seeing patients ready for medication management.

Plus, depression treatment via telehealth is a high-volume, sustainable model. Patients need ongoing medication management (monthly or every-other-month visits), which creates recurring revenue. Unlike one-off evaluations, depression patients stay in your care for months or years, building a stable practice foundation.

If you’re in a shortage state (Texas, Florida, rural Pennsylvania), the demand is enormous. If you’re in a competitive market (New York City, Los Angeles), telehealth lets you expand beyond your local zip code and see patients statewide. Either way, the economics work: you see more patients, spend less time on admin and marketing, and maintain the clinical autonomy you value.

The Bottom Line: Telehealth Depression Prescribing is Wide Open — If You Know the Rules

Here’s what you need to remember:

For psychiatrists (MD/DO):

• You have full prescriptive authority for depression medications in all states — no supervision, no collaborative agreements, no formulary restrictions.
• You can deliver medication management via telehealth and get reimbursed at the same rate as in-person visits thanks to parity laws.
• You must be licensed in the state where the patient is located, but the Interstate Medical Licensure Compact streamlines multi-state licensing.
• Controlled substance prescribing (benzodiazepines, stimulants) is allowed via telehealth through at least the end of 2025 under temporary DEA rules.
• Economics work: $120-$130 per 30-minute visit, 12-16 patients per day, minimal overhead with a platform model.

For PMHNPs:

• Your prescribing authority depends on your state’s scope-of-practice laws:
• Full practice states (New York, soon California): You can prescribe independently, nearly on par with MDs.
• Reduced practice states (Pennsylvania, Illinois): You need a collaborative agreement, but can still manage depression cases with physician support.
• Restricted practice states (Texas, Florida): You must practice under physician supervision or delegation — more administrative burden, but still viable with the right infrastructure.
• Telehealth doesn’t add extra prescribing barriers — state laws apply whether you’re virtual or in-person.
• Reimbursement is mostly equal to MDs from commercial insurance; Medicare pays 85% of physician rates when billing under your NPI.
• Controlled substances depend on state rules: full authority in some states, consultation requirements or delegation in others.

For both provider types:

• Depression prescribing via telehealth is legally straightforward — first-line antidepressants are non-controlled, so no Ryan Haight barriers.
• Patient demand is high — mental health provider shortages in most states, especially Texas, Florida, and rural areas.
• Platform economics beat DIY marketing for most providers: pay per patient instead of upfront marketing gambles, pre-qualified leads, no wasted ad spend.

If you’re ready to expand your practice, reduce administrative headaches, and focus on what you do best — treating depression and improving patients’ lives — telehealth platforms like Klarity offer the infrastructure and patient flow to make it happen.

Ready to join Klarity’s provider network? Explore how our platform connects psychiatrists and PMHNPs with patients who need depression treatment — with zero upfront marketing costs and full control over your schedule. Get started here.

References and Citations

1. California Assembly Bill 890 (AB 890) – Nurse Practitioner Practice. California Legislative Information. September 29, 2020. Available at: https://www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890

2. Florida Nurse Practice Act Updates – House Bill 607 (2020). Florida Association of Nurse Practitioners. Effective July 1, 2020. Available at: https://www.flanp.org/page/PastNewLaws

3. American Association of Nurse Practitioners (AANP). State Practice Environment: Texas. Accessed February 2026. Available at: https://www.aanp.org/advocacy/texas

4. Rivkin Radler LLP. ‘New Law Allows Experienced NPs to Practice Without Physician Collaboration in New York.’ JD Supra. April 13, 2022. Available at: https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/

5. Nurse Practitioner Practice Authority by State – 2026 Update. NursePractitionerOnline.com. Last updated February 5, 2026. Available at: https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/

6. American Association of Nurse Practitioners (AANP). ‘Telehealth Parity Laws by State.’ Referenced via iCanotes.com. April 2025. Available at: https://www.icanotes.com/2022/03/09/telehealth-parity-laws/

7. Texas Nurse Practitioners Association. ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 2024.’ October 6, 2023. Available at: https://texasnp.org/news-laws-and-regulations/

8. Axios News. ‘DEA and HHS Extend COVID-Era Telehealth Prescribing Rules Through End of 2025.’ November 18, 2024. Available at: https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

9. Healing Psychiatry Florida. ‘Psychiatrist Shortage by State: 2026 Data and Rankings.’ January 15, 2026. Available at: https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/

10. PayerPrice.com. ‘CP

Source:

• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.aanp.org/advocacy/texas#:~:text=Regulatory%20Structure
• https://www.flanp.org/page/PastNewLaws#:~:text=must%20engage%20in%20such%20practice,is%20composed%20of%209%20members
• https://texasnp.org/news-laws-and-regulations/#:~:text=,or%20before%20November%2011%2C%202023
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,controlled%20substances%20like%20Adderall%20without
• https://www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890#:~:text=education%2C%20experience%2C%20and%20certification%20requirements,The%20bill%20would%20require%20the
• https://www.icanotes.com/2022/03/09/telehealth-parity-laws/#:~:text=reports%20that%2044%20states%2C%20the,or%20limitations%20in%20their%20implementation
• https://payerprice.com/rates/99214-CPT-fee-schedule#:~:text=National%20average%20reimbursement%20for%20CPT,99214%20by%20major%20payers
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=42%20%20,9%2C318
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=43%20%20,9%2C327